Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

2.

Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction.

Mowatt G, Vale L, Brazzelli M, Hernandez R, Murray A, Scott N, Fraser C, McKenzie L, Gemmell H, Hillis G, Metcalfe M.

Health Technol Assess. 2004 Jul;8(30):iii-iv, 1-207. Review.

3.

Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging.

Iskander S, Iskandrian AE.

J Am Coll Cardiol. 1998 Jul;32(1):57-62. Review.

4.

The coronary calcium treadmill test: a new approach to the initial workup of patients with suspected coronary artery disease.

Rozanski A, Cohen R, Uretsky S.

J Nucl Cardiol. 2013 Oct;20(5):719-30. doi: 10.1007/s12350-013-9763-6. Review.

PMID:
23975601
5.

The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis.

Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE.

J Am Coll Cardiol. 2007 Jan 16;49(2):227-37. Epub 2006 Dec 29. Review.

6.

Diabetes and coronary artery disease: the role of stress myocardial perfusion imaging.

Wackers FJ.

Cleve Clin J Med. 2005 Jan;72(1):21-5, 29-33. Review.

PMID:
15691055
7.

Stress echocardiography: risk stratification, prognosis, patient outcomes and cost-effectiveness.

Yao S, Bangalore S, Ahuja A, Chaudhry FA.

Minerva Cardioangiol. 2009 Jun;57(3):315-31. Review.

PMID:
19513012
8.

Effective risk stratification of patients on the basis of myocardial perfusion SPECT is dependent on appropriate patient selection.

Alexander S, Doukky R.

Curr Cardiol Rep. 2015 Jan;17(1):549. doi: 10.1007/s11886-014-0549-5. Review.

PMID:
25418932
9.

New frontiers in risk stratification using stress myocardial perfusion single photon emission computed tomography.

Hachamovitch R, Berman DS.

Curr Opin Cardiol. 2003 Nov;18(6):494-502. Review.

PMID:
14597891
10.

Nuclear cardiology in acute coronary syndromes.

B├╝low H, Schwaiger M.

Q J Nucl Med Mol Imaging. 2005 Mar;49(1):59-71. Review.

11.

Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies.

Bourque JM, Beller GA.

JACC Cardiovasc Imaging. 2015 Nov;8(11):1309-21. doi: 10.1016/j.jcmg.2015.09.006. Review.

12.

Noninvasive monitoring of medical therapy.

Kudes MA, Schwartz RG.

Curr Cardiol Rep. 2006 Mar;8(2):139-46. Review.

PMID:
16524541
13.
15.

Advances in nuclear imaging for preoperative risk assessment.

Eddinger J, Cohen MC.

Curr Cardiol Rep. 2005 Mar;7(2):143-7. Review.

PMID:
15717962
17.

Coronary vasomotor function assessed by positron emission tomography.

Tamaki N, Yoshinaga K, Naya M.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1213-24. doi: 10.1007/s00259-009-1311-x. Epub 2009 Nov 24. Review.

PMID:
19937243
18.

Cost-effectiveness of myocardial perfusion imaging: a summary of the currently available literature.

Des Prez RD, Shaw LJ, Gillespie RL, Jaber WA, Noble GL, Soman P, Wolinsky DG, Williams KA.

J Nucl Cardiol. 2005 Nov-Dec;12(6):750-9. Review. No abstract available.

PMID:
16344238
19.

Assessment of prognosis in chronic coronary artery disease.

Bateman TM, Prvulovich E.

Heart. 2004 Aug;90 Suppl 5:v10-5. Review. No abstract available.

20.

Supplemental Content

Support Center